Cargando…
Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait
BACKGROUND: Freezing of gait (FoG) is a common and debilitating condition in Parkinson’s disease (PD) associated with executive dysfunction. A subtype of FoG does not respond to dopaminergic therapy and may be related to noradrenergic deficiency. This pilot study explores the effects of atomoxetine...
Autores principales: | Revuelta, Gonzalo J., Embry, Aaron, Elm, Jordan J., Gregory, Chris, Delambo, Amy, Kautz, Steve, Hinson, Vanessa K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676139/ https://www.ncbi.nlm.nih.gov/pubmed/26693006 http://dx.doi.org/10.1186/s40035-015-0047-8 |
Ejemplares similares
-
A feasibility study of objective outcome measures used in clinical trials of freezing of gait
por: Revuelta, Gonzalo J., et al.
Publicado: (2022) -
Utility of objective gait measures in levodopa‐unresponsive freezing in Parkinson's
por: Virmani, Tuhin, et al.
Publicado: (2021) -
Differences in Brain Activity Between Dopa-Responsive and -Unresponsive Pain in Parkinson’s Disease
por: Zheng, Jin Hua, et al.
Publicado: (2022) -
l-DOPA and Freezing of Gait in Parkinson’s Disease: Objective Assessment through a Wearable Wireless System
por: Suppa, Antonio, et al.
Publicado: (2017) -
Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Unresponsive Freezing of Gait after Deep Brain Stimulation in Parkinson's Disease
por: González-Herrero, Belén, et al.
Publicado: (2020)